Beauty dealmaking heats up with Trilogy and Thriving Brands portfolio expansions

Beauty and personal care dealmaking is ripe across skin care, hair care, and ingredients, as companies acquire brands to scale science-backed portfolios, manufacturing capabilities, and global market reach.

Trilogy Laboratories has acquired YNS Cosmeceuticals, incorporating its pharmaceutical heritage and FDA-compliant manufacturing capabilities into the skin care brand. YNS has a background in clean beauty aligned with “skinimalism” trends.

Meanwhile, UK-based beauty incubator SLG Brands has finalized the offload of two of its flagship hair care brands to Thriving Brands. Colab Dry Shampoo and Johnny’s Chop Shop will enter the US-based acquisition platform’s repertoire of everyday personal care brands.

Trilogy’s beauty-focused acquisition

Trilogy states that part of the motivation for its acquisition of YNS was to avoid introducing a new skin care line in an already saturated market, but to leverage YNS’s existing consumer base.

YNS’s portfolio is honed into its signature Power Trio: Cell-Tight, Infusion O2, and Radiance. The ethos of the brand is simplicity with high efficacy, focusing on minimalist routines consisting of products that complement each other.

The acquisition is said to embolden YNS’s manufacturing capabilities with the support of Trilogy’s existing manufacturing infrastructure.

Trilogy boasts an FDA-registered cosmetic manufacturing facility and offers formulation development, manufacturing, quality assurance, regulatory oversight, and product innovation to skin care brands. 

“We acquired YNS because it already represented many of the qualities we value most — thoughtful formulations, a clear philosophy, and the trust of its customers,” says Dr. Kristen Flaharty, CEO at Trilogy Laboratories. “Our responsibility is to preserve that foundation while supporting the brand’s future with pharmaceutical formulation expertise, physician leadership, and continued innovation.”

Trilogy says that the acquisition is meant to provide “continuity rather than change” for existing YNS customers.

Scaling hair with Thriving Brands

Trilogy Laboratories has acquired YNS Cosmeceuticals to strengthen its science-backed skin care portfolio.

Of Thriving Brands’ acquisitions, Colab is a science-backed dry shampoo brand, and Johnny’s Chop Shop operates in the men’s grooming and hair care space.

“We conceived and founded Colab and Johnny’s Chop Shop and grew them into internationally recognized brands. This transaction frees SLG to focus on what comes next,” says Lucy Beresford, CEO at SLG Brands.

 Craig Cappozzo, CEO of Thriving Brands, adds: “Colab and Johnny’s Chop Shop are the kind of brands that win on shelf because they were built with genuine consumer insight and cultural relevance.”

“Our job is to protect what makes them work and scale what makes them grow. SLG established an exceptional foundation — we’re here to build the next chapter.”

Thriving Brands’ existing portfolio includes men’s body care brand Right Guard and deodorant label Dry Idea Brands. The company maintains a dedicated growth platform across various industries and markets.

Industry acquisitions

In other industry acquisitions, Solabia Group has completed its acquisition of Mibelle Biochemistry, the Swiss specialist in science-backed active ingredients for the cosmetics and nutraceutical industries. Talks of the deal, from Persán, were initially announced in February 2026.

Last week, Elkem Silicones rebranded as Bluestar Silicones, following Bluestar’s acquisition of the majority of Elkem’s Silicone division in late April. The move marks a milestone in the global silicone manufacturer’s transition.

In hair care, Henkel is set to take over prestige brand Olaplex for a total transaction value of US$1.4 billion. Personal Care Insights initially reported on the rumored deal in January. Following the talks, Olaplex shares jumped 20% in afternoon trading on January 7. The uptick was a turnaround from the hair care brand’s stock, which had fallen approximately 94% since its market debut. Now, Olaplex will no longer be listed on Nasdaq, and Advent International will fully exit its investment in the company at close.